Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Reno

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1991
Development and biologic evaluation of a kit for preformed chelate technetium-99m radiolabeling of an antibody Fab fragment using a diamide dimercaptide chelating agentS Kasina, T N Rao, A Srinivasan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1989
Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancerD S Wilbur, S W Hadley, M D Hylarides, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 2000
Clinical optimization of pretargeted radioimmunotherapy with antibody-streptavidin conjugate and 90Y-DOTA-biotinH B Breitz, P L Weiden, P L Beaumier, et al.
Bioconjugate Chemistry|February 14, 1998
Simplified preformed chelate protein radiolabeling with technetium-99m mercaptoacetamidoadipoylglycylglycine (N3S-adipate)S Kasina, J A Sanderson, J N Fitzner, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1988
Specific and stable labeling of antibodies with technetium-99m with a diamide dithiolate chelating agentA R Fritzberg, P G Abrams, P L Beaumier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1989
Successful imaging of malignant melanoma with technetium-99m-labeled monoclonal antibodiesJ F Eary, R W Schroff, P G Abrams, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2000
Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicityD B Axworthy, J M Reno, M D Hylarides, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 1999
Molecular modeling and preclinical evaluation of the humanized NR-LU-13 antibodyS S Graves, S C Goshorn, D M Stone, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 31, 2000
Neurotrophic actions of a novel molluscan epidermal growth factorP M Hermann, R E van Kesteren, W C Wildering, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1991
Development and biologic evaluation of a kit for preformed chelate technetium-99m radiolabeling of an antibody Fab fragment using a diamide dimercaptide chelating agentS Kasina, T N Rao, A Srinivasan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1989
Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancerD S Wilbur, S W Hadley, M D Hylarides, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 2000
Clinical optimization of pretargeted radioimmunotherapy with antibody-streptavidin conjugate and 90Y-DOTA-biotinH B Breitz, P L Weiden, P L Beaumier, et al.
Bioconjugate Chemistry|February 14, 1998
Simplified preformed chelate protein radiolabeling with technetium-99m mercaptoacetamidoadipoylglycylglycine (N3S-adipate)S Kasina, J A Sanderson, J N Fitzner, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1988
Specific and stable labeling of antibodies with technetium-99m with a diamide dithiolate chelating agentA R Fritzberg, P G Abrams, P L Beaumier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1989
Successful imaging of malignant melanoma with technetium-99m-labeled monoclonal antibodiesJ F Eary, R W Schroff, P G Abrams, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2000
Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicityD B Axworthy, J M Reno, M D Hylarides, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 1999
Molecular modeling and preclinical evaluation of the humanized NR-LU-13 antibodyS S Graves, S C Goshorn, D M Stone, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 31, 2000
Neurotrophic actions of a novel molluscan epidermal growth factorP M Hermann, R E van Kesteren, W C Wildering, et al.
Pageof 2